Visinoni Franco
Milestone Srl, Via Fatebenefratelli 1/5, 24010, Sorisole Bergamo, Italy,
Recent Results Cancer Res. 2015;199:119-33. doi: 10.1007/978-3-319-13957-9_12.
In anatomic pathology, the current state encompassing the pre-analytic processes of tissue collection, handling, examination, preparation, processing, and storage are largely uncontrolled, inconsistently performed, and/or not standardized according to the sound scientific data. Pre-analytic defects result in nearly three-quarters of the problems in laboratory diagnostics. This is evident in quality surveys from well-respected institutions that document high miss rates in the required basics of information related to patient and tissue identity, let alone parameters documenting quality aspects related to the surgical specimen and its preservation. This talk will describe the historical approach to tissue processing and identify gaps from worldwide observations in current laboratory practices. It will also offer potential methodological and technological solutions and process improvements that laboratories may consider in serving the ultimate users of pathology information: the clinician and the patient. It illustrates the need for scientifically validated specimen guidelines and a performance based, standardized and documented "chain of custody" of the pre-analytical steps from the patient's body through fixation. For thought leaders and professional standard setters, opportunities for optimizing molecular studies exist in specimen collection, transfer, grossing, fixation, and decalcification protocols. In this evolving era of molecular profiling and personalized therapeutic decision-making, a well-reasoned and coordinated focus on pre-analytic processes that optimizes specimens for subsequent testing will result in: Improved specimen quality for molecular testing Improved accuracy of diagnostic and molecular test results Reduced Turnaroundtimes for same-day diagnosis Enhanced satisfaction of clinicians and patients.
在解剖病理学中,目前涵盖组织采集、处理、检查、制备、加工和储存等分析前过程的状况在很大程度上不受控制、执行不一致,和/或未根据可靠的科学数据进行标准化。分析前的缺陷导致实验室诊断中近四分之三的问题。这在备受尊敬的机构进行的质量调查中很明显,这些调查记录了在与患者和组织身份相关的所需基本信息方面的高遗漏率,更不用说记录与手术标本及其保存相关质量方面的参数了。本次演讲将描述组织处理的历史方法,并识别当前实验室实践中全球观察结果存在的差距。它还将提供实验室在服务病理学信息的最终用户:临床医生和患者时可能考虑的潜在方法和技术解决方案以及流程改进。它说明了科学验证的标本指南以及从患者身体到固定的分析前步骤基于性能、标准化和有记录的“保管链”的必要性。对于思想领袖和专业标准制定者来说,在标本采集、转移、大体检查、固定和脱钙方案中存在优化分子研究的机会。在这个分子谱分析和个性化治疗决策不断发展的时代,对分析前过程进行合理且协调的关注,以优化标本用于后续检测,将带来以下结果:提高分子检测的标本质量提高诊断和分子检测结果的准确性缩短当日诊断的周转时间提高临床医生和患者的满意度。